Symptomatic onset of severe hemophilia A in childhood is dependent on the presence of prothrombotic risk factors

Thrombosis and Haemostasis

Volumn 85, Issue 2, 2001, Pages 218-220

  Ettingshausen, C E ^a   Halimeh, S ^a   Kurnik, K ^a   Schobess, R ^a   Wermes, C ^a   Junker, R ^a   Kreuz, W ^a   Pollmann, H ^a   Nowak Gottl U ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Factor V G1691A; Pediatric PUP patients; Prothrombin G20210A; Severe hemophilia A

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; PROTEIN C; PROTEIN S; PROTHROMBIN;

ARTICLE; BLEEDING; BLOOD CLOTTING FACTOR 5 DEFICIENCY; CARDIOVASCULAR RISK; CHILD; CHILDHOOD; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE CARRIER; DISEASE SEVERITY; GENE MUTATION; GENOTYPE; HEMOPHILIA A; HUMAN; INFANT; MAJOR CLINICAL STUDY; ONSET AGE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN VARIANT; PROTHROMBIN DEFICIENCY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL; THROMBOSIS;

EID: 0035129399     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1615679     Document Type: Article

References (27)

1. Hemophilia A
2. Hemophilia in the first year of life
3. Initial presentations of hemophiliacs
4. Diagnostic symptoms of severe and moderate haemophilia A and B
5. Cephalhaematoma: A 10-year review
6. Risk from circumcision during the first month of life compared with those for uncircumcised boys
7. Platelet coagulant activities and clinical severity in hemophilia
8. Factor IXa- factor VIIIa- cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo
9. Deep venous thrombosis in hemophilia A
10. Central venous catheter-associated thrombosis in severe haemophilia
11. Fatal myocardial infarction following therapy with prothrombin complex concentrates in a young man with hemophilia A
12. Acute myocardial infarction complicating prothrombin complex concentrate therapy in an 8-year-old boy with hemophilia A and factor VIII inhibitor
13. Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor
14. Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of factor VIII after intamural jejunal bleeding - Successful thrombolysis under heparin therapy
15. Cerebral infarction associated with factor V Leiden mutation in a boy with hemophilia A
16. Inherited thrombophilia: Part 1
17. Mutation in blood coagulation factor V associated with resistance to activated protein C
18. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
19. Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia
20. Small deletion/insertion mutations within poly-A runs of the factor VIII gene mitigate the severe haemophilia A phenotype
21. Moderation of hemophilia A phenotype by the factor V R506Q mutation
22. Inversions disrupting the factor VIII gene are a common cause of severe haemophilia A
23. Low prevalence of the factor V Leiden mutation among "severe" hemophiliacs with a "milder" bleeding diathesis
24. Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A
25. Treatment of haemophilia
26. Coagulation factor concentrates by continuous infusion
27. Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss - A possible evolutionary selection mechanism